American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

@article{Hammond2010AmericanSO,
  title={American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).},
  author={M Elizabeth Hale Hammond and Daniel F Hayes and Mitch Dowsett and Donald C Allred and Karen L. Hagerty and Sunil S. Badve and Patrick L. Fitzgibbons and Glenn D. Francis and Neil S. Goldstein and Malcolm Hayes and David G. Hicks and Susan E. Lester and Richard Love and Pamela B. Mangu and Lisa M. McShane and Keith W. Miller and C. Kent Osborne and Soonmyung Paik and Jane Perlmutter and A Rhodes and Hironobu Sasano and Jared N. Schwartz and Fred C G Sweep and Sheila E. Taube and Emina Emilia Torlakovic and Paul Valenstein and Giuseppe Viale and Daniel W. Visscher and Thomas M. Wheeler and R Bruce Williams and James L Wittliff and Antonio C. Wolff},
  journal={Archives of pathology & laboratory medicine},
  year={2010},
  volume={134 7},
  pages={
          e48-72
        }
}
  • M Elizabeth Hale Hammond, Daniel F Hayes, +29 authors Antonio C. Wolff
  • Published 2010
  • Medicine
  • Archives of pathology & laboratory medicine
  • PURPOSE To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the utility of these receptors as predictive markers. METHODS The American Society of Clinical Oncology and the College of American Pathologists convened an international Expert Panel that conducted a systematic review and evaluation of the literature in partnership with Cancer Care Ontario and developed recommendations for… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Glucose starvation and metformin have synergistic antitumor effects that are mediated through the concomitant inhibition of glycolysis and mitochondrial oxidative phosphorylation. The… Expand
    ConditionsTriple-negative Breast Cancer
    InterventionDietary Supplement, Drug
    OBSERVATIONAL CLINICAL TRIAL
    This is a translational study in patients with operated early breast cancer of Luminal A or Luminal B sub types.The Hellenic Cooperative Oncology Group (HeCOG) has designed an… Expand
    ConditionsBreast Cancer
    INTERVENTIONAL CLINICAL TRIAL
    This study compared long term outcome of stage IIIB/C and IV breast cancer patients treated with neoadjuvant hormonal therapy (NAHT) and those treated with neoadjuvant chemotherapy… Expand
    ConditionsBreast Cancer
    InterventionDrug, Procedure

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 443 CITATIONS, ESTIMATED 59% COVERAGE

    Systematic Review on Hormone Receptor Testing in Breast Cancer

    FILTER CITATIONS BY YEAR

    2010
    2020

    CITATION STATISTICS

    • 11 Highly Influenced Citations

    • Averaged 54 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 91 REFERENCES

    Consensus Recommendations on Estrogen Receptor Testing in Breast Cancer By Immunohistochemistry

    VIEW 1 EXCERPT

    American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

    VIEW 2 EXCERPTS